Literature DB >> 33090884

Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown.

Vincenzo Russo1, Pia Clara Pafundi2, Antonio Rapacciuolo3, Antonello D'Andrea4, Marcello de Devitiis5, Mario Volpicelli6, Antonio Ruocco7, Gerardo Nigro1, Antonio D'Onofrio8.   

Abstract

Introduction: Following the coronavirus disease (COVID-19) outbreak, the Italian government adopted strict rules of lockdown and social distancing. The aim of our study was to assess admission rate for syncope leading to cardiac rhythm management (CRM) procedures in Campania, the third-most-populous region of Italy, during COVID-19 lockdown.
Methods: Data were sourced from 14 referral hospitals in Campania from 10th March to 4 May 2020 (lockdown period) and during the same period in 2019. Among consecutive patients hospitalized for CRM procedures during the two observational periods, we retrospectively evaluated those admitted for arrhythmogenic syncope. Admission rate and the type of hospital admission between the two observational periods were compared.
Results: Among 951 consecutive patients hospitalized for CRM procedures, 204 were admitted for arrhythmogenic syncope leading to CRM procedures. A significant increase in admission was shown in 2020 compared to 2019 (26.4% vs. 18.3%; P = 0.003). Moreover, regarding the type of admission to hospitals, attendance at the emergency department (ED) significantly increased (83.5% vs. 56.1%; P < 0.001); conversely, a significant decrease in urgent unplanned hospitalizations (6.2% vs. 35.5%; P < 0.001) was observed during COVID-19 lockdown. Conclusions: The hospitalization for arrhythmogenic syncope leading to CRM procedures increased during COVID-19 lockdown.

Entities:  

Keywords:  Arrhythmias; COVID-19 defibrillator; cardiac implanted device; hospitalization; pacemaker; syncope

Year:  2020        PMID: 33090884     DOI: 10.1080/17434440.2020.1841632

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

1.  Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.

Authors:  Vincent Issac Lau; Sumeet Dhanoa; Harleen Cheema; Kimberley Lewis; Patrick Geeraert; David Lu; Benjamin Merrick; Aaron Vander Leek; Meghan Sebastianski; Brittany Kula; Dipayan Chaudhuri; Arnav Agarwal; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Danny J Zuege; Oleksa G Rewa; Sean M Bagshaw
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  The Impact of the COVID-19 Outbreak on Patients' Adherence to PCSK9 Inhibitors Therapy.

Authors:  Valentina Maria Caso; Simona Sperlongano; Biagio Liccardo; Emanuele Romeo; Sergio Padula; Fortunato Arenga; Antonello D'Andrea; Pio Caso; Paolo Golino; Gerardo Nigro; Vincenzo Russo
Journal:  J Clin Med       Date:  2022-01-18       Impact factor: 4.241

3.  COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy).

Authors:  Ivan Gentile; Martina Iorio; Emanuela Zappulo; Riccardo Scotto; Alberto Enrico Maraolo; Antonio Riccardo Buonomo; Biagio Pinchera; Giuseppina Muto; Carmela Iervolino; Riccardo Villari; Nicola Schiano Moriello; Maria Michela Scirocco; Maria Triassi; Mariano Paternoster; Vincenzo Russo; Giulio Viceconte
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.